Details for 2008732695

Up to date per 01.04.2026

Actions

Title / Product Name

PHARMAZEUTISCHE FORMULIERUNGEN MIT DAPAGLIFLOZIN-PROPYLENGLYCOL-HYDRAT

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2008732695

EP Publication Number

2139494

E-Number

1242301

Language

PCT Number

US08057888

Publication Date

06.01.2010 A

11.03.2020 B1

Registration Date

11.03.2020

AT Publication Date

15.03.2020

Application Date

21.03.2008

Registration Number

Priorities

22.03.2007

896286 P

IPC

A61K 31/70 20060101AFI20190730BHEP

Maximum Duration of Protection

21.03.2028

Owner

AstraZeneca AB 151 85 SödertäljeSE

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

BINDRA, Dilbir, S.1 Squibb Drive New Brunswick, NJ 08903US

DALI, Mandar, V.1 Squibb Drive New Brunswick, NJ 08903US

PARAB, Prakash, V.1 Squibb Drive New Brunswick, NJ 08903US

PATEL, Jatin, M.1 Squibb Drive New Brunswick, NJ 08903US

TAO, Li1 Squibb Drive New Brunswick, NJ 08903US

TEJWANI, Ravindra, W.1 Squibb Drive New Brunswick, NJ 08903US

VATSARAJ, Nipa1 Squibb Drive New Brunswick, NJ 08903US

WU, Yongmei1 Squibb Drive New Brunswick, NJ 08903US

Information about Fees